Mid-cap Health Care company Elanco Animal Health has logged a -1.4% change today on a trading volume of 5,239,860. The average volume for the stock is 5,791,231.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Based in Greenfield, United States the company has 9,000 full time employees and a market cap of $4,574,496,768.
The company is now trading -32.77% away from its average analyst target price of $13.81 per share. The 8 analysts following the stock have set target prices ranging from $9.5 to $19.0, and on average give Elanco Animal Health a rating of hold.
Over the last 12 months ELAN shares have declined by -21.0%, which represents a difference of -43.0% when compared to the S&P 500. The stock's 52 week high is $14.69 per share and its 52 week low is $7.88. With its net margins declining an average -23.0% over the last 5 years, Elanco Animal Health declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-03-01 | 4,411,000 | -78,000 | -2 | 80.0 |
| 2022-02-28 | 4,764,000 | -483,000 | -10 | 44.44 |
| 2021-03-01 | 3,271,000 | -574,000 | -18 | -1000.0 |
| 2020-02-28 | 3,071,000 | 68,000 | 2 | -33.33 |
| 2019-02-13 | 3,066,800 | 86,500 | 3 |
